Hydrogen sulfide: An endogenous mediator of resolution of inflammation and injury

Antioxidants and Redox Signaling

Volumn 17, Issue 1, 2012, Pages 58-67

  Wallace, John L ^a,b   Ferraz, Jose G P ^b   Muscara, Marcelo N ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 346; ACETYLSALICYLIC ACID; ATB 346; CAPSAICIN; CARRAGEENAN; CELECOXIB; GLIBENCLAMIDE; HYDROGEN SULFIDE; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPARGYLGLYCINE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; ZINC ACETATE;

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; APOPTOSIS; COLITIS; COLON MUCOSA; DRUG EFFICACY; ENERGY RESOURCE; HUMAN; INFLAMMATION; INJURY; INTESTINE CELL; MACROPHAGE; MITOCHONDRIAL RESPIRATION; MONARTHRITIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STOMACH ULCER; TISSUE INJURY; ULCER HEALING;

ANIMALS; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; WOUND HEALING;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE;

EID: 84860721674     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4351     Document Type: Review

References (76)

1. Abe K and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Andruski B, McCafferty DM, Ignacy T, Millen B, and McDougall JJ. Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis. Am J Physiol Regul Integr Comp Physiol 295: R814-R820, 2008.
3. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, and Wallace JL. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol 281: G635-G644, 2001.
4. Attene-Ramos MS, Wagner ED, Plewa MJ, et al. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4: 9-14, 2006.
5. Babidge W, Millard S, and Roediger W. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol Cell Biochem 181: 117-124, 1998.
6. Bai AP, Ouyang Q, and Hu RW. Diallyl trisulfide inhibits tumor necrosis factor-alpha expression in inflamed mucosa of ulcerative colitis. Dig Dis Sci 50: 1426-1431, 2005.
7. Benavides GA, Squadrito GL, Mills RW, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104: 17977-17982, 2007.
8. Brancaleone V, Sampaio A, Cirino C, Flower RJ, and Perretti M. A novel cross-talk in resolution: H2S activates the annexin A1 pathway. Inflammation Res, in press.
9. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, and Cirino G. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30: 1998-2004, 2010.
10. Caliendo G, Cirino G, Santagada V, and Wallace JL. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 53: 6275-6286, 2010.
11. Cao Q, Zhang L, Yang G, Xu C, and Wang R. Butyratestimulated H2S production in colon cancer cells. Antioxid Redox Signal 12: 1101-1109, 2010.
12. Chen YH, Wang PP, Wang XM, He YJ, Yao WZ, Qi YF, and Tang CS. Involvement of endogenous hydrogen sulfide in cigarette smoke-induced changes in airway responsiveness and inflammation of rat lung. Cytokine 53: 334-341, 2011.
13. Cunha TM, Dal-Secco D, Verri WA Jr, Guerrero AT, Souza GR, Vieira SM, Lotufo CM, Neto AF, Ferreira SH, and Cunha FQ. Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. Eur J Pharmacol 590: 127-135, 2008.
14. Distrutti E, Sediari L, Mencarelli A, et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 316: 325-335, 2006.
15. Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, Cirino G, Wallace JL, and Fiorucci S. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther 319: 447-458, 2006.
16. Dufton N and Wallace JL. Phenotypic differences in hydrogen sulfide synthesis and signaling in primary macrophages. Inflammation Res 60: 121, 2011.
17. Ekundi-Valentim E, Santos KT, Camargo EA, Denadai-Souza A, Teixeira SA, Zanoni CI, Grant AD, Wallace J, MuscaráMN, and Costa SK. Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br J Pharmacol 159: 1463-1474, 2010.
18. Fiorucci S, Antonelli E, Distrutti E, Mencarelli A, Orlandi S, Zanardo R, Renga B, Rizzo G, Morelli A, Cirino G, and Wallace JL. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129: 1210-1224, 2005.
19. Fiorucci S, Mencarelli A, Caliendo G, Santagada V, Distrutti E, Santucci L, Cirino G, and Wallace JL. Enhanced activity of a hydrogen-sulfide releasing mesalamine derivative (ATB-429) in a mouse model of colitis. Br J Pharmacol 150: 996-1002, 2007.
20. Flannigan KL, McCoy KD, and Wallace JL. Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis. Am J Physiol Gastrointest Liver Physiol 301: G188-G193, 2011.
21. Furne JK, Suarez FL, Koenig T, DeMaster E, and Levitt MD. Oxidation of hydrogen sulfide and methanethiol to thiolsulfate by rat tissues: a specialized function of the colonic mucosa. Biochem Pharmacol 62: 255-259, 2001.
22. Goubern M, Andriamihaja M, Nübel T, et al. Sulfide, the first inorganic substrate for human cells. FASEB J 21: 1699-1706, 2007.
23. Han W, Dong Z, Dimitropoulou C, Su Y. Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. Antioxid Redox Signal 15: 2121-2134, 2011.
24. Hosoki R, Matsuki N, and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
25. Jorgensen J and Mortensen PB. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. Dig Dis Sci 46: 1722-1732, 2001.
26. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, and Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 1797: 1500-1511, 2010.
27. Levine J, Ellis CJ, Furne JK, et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93: 83-87, 1998.
28. Levitt MD, Springfield J, Furne J, et al. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production. J Appl Physiol 92: 1655-1660, 2002.
29. Li L, Rose P, and Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51:169-187, 2011.
30. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, and Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42: 706-719, 2007.
31. Liu H, Bai XB, Shi S, and Cao YX. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J Pharm Pharmacol 61: 207-212, 2009.
32. Macfarlane GT, Gibson GR, and Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72: 57-64, 1992.
33. Magee EA, Richardson CJ, Hughes R, et al. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 72: 1488-1494, 2000.
34. Mariggio MA, Minunno V, Riccardi S, Santacroce R, De Rinaldis P, and Fumarulo R. Sulfide enhancement of PMN apoptosis. Immunopharmacol Immunotoxicol 20: 399-408, 1998.
35. Martin GR, McKnight GW, Dicay M, Coffin CS, Ferraz JG, and Wallace JL. Hydrogen sulfide synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis 42: 103-109, 2010.
36. Martin GR, Perretti M, Flower RJ, and Wallace JL. Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol 294: G764-G769, 2008.
37. Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K, Yoshida S, Takemura M, and Kawabata A. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58: 751-671, 2009.
38. Moore J, Babidge W, Millard S, et al. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 43: 162-165, 1998.
39. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, and Chung HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119, 2006.
40. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, and SzabóC. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106: 21972-21977, 2009.
41. Perretti M and D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9: 62-70, 2009.
42. Picton R, Eggo MC, Langman MJ, et al. Impaired detoxification of hydrogen sulfide in ulcerative colitis? Dig Dis Sci 52: 373-378, 2007.
43. Pitcher MC, Beatty ER, and Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46: 64-72, 2000.
44. Reiffenstein RJ, Hulbert WC, and Roth SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 32:109-134, 1992.
45. Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 2: 712-715, 1980.
46. Roediger WE, Duncan A, Kapaniris O, et al. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin Sci (Lond) 85: 623-627, 1993.
47. Schicho R, Krueger D, Zeller F, et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon. Gastroenterology 131: 1542-1552, 2006.
48. Searcy DG and Lee SH. Sulfur reduction by human erythrocytes. J Exp Zool 282: 310-322, 1998.
49. Serhan CN, Brain SD, Buckley C, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, and Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21: 325-332, 2007.
50. Shibuya N, Mikami Y, Kimura Y, Nagahara N, and Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: 623-626, 2009.
51. Suarez F, Furne J, Springfield J, et al. Production and elimination of sulfur-containing gases in the rat colon. Am J Physiol 274: G727-G733, 1998.
52. Theissen U, Hoffmeister M, Grieshaber M, and Martin W. Single eubacterial origin of eukaryotic sulfide:quinone oxidoreductase, a mitochondrial enzyme conserved from the early evolution of eukaryotes during anoxic and sulfidic times. Mol Biol Evol 20: 1564-1574, 2003.
53. Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes WM, Kundu S, and Tyagi SC. H2S protections against methionine-induced oxidative stress in rain endothelial cells. Antiox Redox Signal 11: 25-33, 2009.
54. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28: 501-505, 2007.
55. Wallace JL. Prostaglandins, NSAIDs and mucosal defence. Why doesn't the stomach digest itself? Physiol Reviews 88: 1547-1565, 2008.
56. Wallace JL. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid Redox Signal 12: 1125-1133, 2010.
57. Wallace JL. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol, in press.
58. Wallace JL, Caliendo G, Santagada V, and Cirino G. Markedly reduced toxicity of a hydrogen sulfide-releasing derivative of naproxen (ATB-346). Br J Pharmacol 159: 1236-1246, 2010.
59. Wallace JL, Caliendo G, Santagada V, Cirino G, and Fiorucci S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132: 261-271, 2007.
60. Wallace JL, Dicay M, McKnight W, and Martin GR. Hydrogen sulfide enhances ulcer healing. FASEB J 2007; 21: 4070-4076.
61. Wallace JL, Vong L, McKnight W, Dicay M, and Martin GR. Endogenous and exogenous hydrogen sulphide promotes resolution of colitis in rats. Gastroenterology 137: 569-578, 2009.
62. Wang L and Wallace JL. Hydrogen sulfide reduces cardioautonomic responses to gastric distention (GD) in an ATPsensitive potassium channel (KATP)-dependent manner. Neurogastroenterology and Motility 23(Suppl 1): 18, 2011.
63. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798j, 2002.
64. Whiteman M, Armstrong JS, Chu SH, Siau JL, Wong BS, Cheung NS, Halliwell B, and Moore PK. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite scavenger? J Neurochem 90: 765-768, 2004.
65. Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL,Wong BS, Armstrong JS, and Moore PK. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 326: 794-798, 2005.
66. Whiteman M, Haigh R, Tarr JM, Gooding KM, Shore AC, and Winyard PG. Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann NY Acad Sci 1203: 146-150, 2010.
67. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, andMoore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 12: 1147-1154, 2010.
68. Xu XM, Yu JP, He XF, Li JH, Yu LL, and Yu HG. Effects of garlicin on apoptosis in rat model of colitis. World J Gastroenterol 11: 4579-4582, 2005.
69. Xu ZS, Wang XY, Xiao DM, Hu LF, Lu M, Wu ZY, and Bian JS. Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic Biol Med 15: 1314-1323, 2011.
70. Zamuner SR, Bak AW, Devchand PR, and Wallace JL. Predisposition to colorectal cancer in ratswith resolved colitis: role of COX-2-derived PGD2. Am J Pathol 167: 1293-1300, 2005.
71. Zamuner SR, Warrier N, Buret AG, MacNaughton WK, and Wallace JL. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 52: 1714-1720, 2003.
72. Zanardo RCO, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, and Wallace JL. Hydrogen sulphide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118-2120, 2006.
73. Zhao W and Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol 283: H474-H480, 2002.
74. Zhao W, Zhang J, Lu Y, and Wang R. The vasorelaxant effects of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008-6016, 2001.
75. Zhong GZ, Chen RF, Cheng YQ, Tang CS, and Du JB. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1879-1885, 2003.
76. Zuidema MY, Yang Y, Wang M, Kalogeris T, Liu Y, Meininger CJ, Hill MA, Davis MJ, and Korthuis RJ. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels. Am J Physiol Heart Circ Physiol 299: H1554-H1567, 2010.